Impotence evaluated by the use of prostaglandin E1

T. I.S. Hwang, C. R. Yang, S. J. Wang, C. L. Chang, T. S. Tzai, C. H. Chang, H. C. Wu

Research output: Contribution to journalArticlepeer-review

33 Scopus citations


We screened 80 patients at our hospital for the differential diagnosis of impotence using intracavernous injection of prostaglandin E1 (20 μg.). The rate of positive response was 78.8 per cent (63 patients). Neither systemic reactions nor priapism occurred. However, a considerable incidence (23.8 per cent, 19 of 80 patients) of tolerable injection pain was encountered. The 133xenon penile washout study was conducted routinely in impotent men for hemodynamic evaluation of penile vascularity. In 80 patients a positive correlation between the response of intracavernous prostaglandin E1 injection and the result of the washout study was found (r equals 0.381, p less than 0.0002). We selected 14 subjects randomly to receive additional intravenous infusions of prostaglandin E1 (6 ampules, 120 μg. total) for 3 days, after which another 133xenon washout study was done. The washout studies before and after intravenous prostaglandin E1 infusion were compared, and 10 patients (71.4 per cent) appeared to obtain improvement in half-time clearance and penile blood flow. However, only 3 patients noticed improvement subjectively. We suggest that prostaglandin E1 could be a desirable alternative for the diagnosis and treatment of impotence.

Original languageEnglish
Pages (from-to)1357-1359
Number of pages3
JournalJournal of Urology
Issue number6
StatePublished - 1989


Dive into the research topics of 'Impotence evaluated by the use of prostaglandin E1'. Together they form a unique fingerprint.

Cite this